APA (7th ed.) Citation

O, G., O, L., M, G., R, E., E, M., B, P., . . . AB, A. (2016). Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer. American journal of clinical oncology, 39(1), 37. https://doi.org/10.1097/COC.0000000000000011

Chicago Style (17th ed.) Citation

O, Gemer, et al. "Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer." American Journal of Clinical Oncology 39, no. 1 (2016): 37. https://doi.org/10.1097/COC.0000000000000011.

MLA (9th ed.) Citation

O, Gemer, et al. "Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer." American Journal of Clinical Oncology, vol. 39, no. 1, 2016, p. 37, https://doi.org/10.1097/COC.0000000000000011.